Attached files

file filename
EX-23.2 - EXHIBIT 23.2 - Vaxart, Inc.ex23-2.htm
EX-23.1 - EXHIBIT 23.1 - Vaxart, Inc.ex23-1.htm
EX-32.2 - EXHIBIT 32.2 - Vaxart, Inc.ex32-2.htm
EX-21.1 - EXHIBIT 21.1 - Vaxart, Inc.ex21-1.htm
EX-23.1A - EXHIBIT 23.1A - Vaxart, Inc.ex23-1a.htm
EX-31.1 - EXHIBIT 31.1 - Vaxart, Inc.ex31-1.htm
EX-31.2 - EXHIBIT 31.2 - Vaxart, Inc.ex31-2.htm
10-K - FORM 10-K - Vaxart, Inc.bota20150630_10k.htm

 

Exhibit 32.1

 

Certification Pursuant To Section 906 of the

Sarbanes-Oxley Act 2002

 

        In connection with the Annual Report on Form 10-K of Biota Pharmaceuticals, Inc. (the "Company") for the year ended June 30, 2015, as filed with the Securities and Exchange Commission on the date hereof (the "Report"), the undersigned hereby certifies, pursuant to 18 U.S.C. ss. 1350, as adopted pursuant to ss. 906 of the Sarbanes-Oxley Act of 2002, that:

 

        1. The report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

 

        2. The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

 

 

                           /s/ Joseph M. Patti

                            -----------------------------------------------------

 President, Chief Executive Officer (Principal Executive Officer)

 

 

 

September 11, 2015